You may remember the hubbub about four years ago, when it emerged that antidepressants can cause suicidal thoughts in kids. After investigating the issue, the FDA ordered companies to place a "black box" warning noting suicidality as a potential side effect of the medication. But antidepressants aren't the only drugs that can cause psychiatric problems. The New York Times linkurl:reported;http://www.nytimes.com/2008/01/24/washington/24fda.html?ref=health&pagewanted=print yesterday (January 24) that the agency is now going to demand that companies making drugs for treating conditions such as obesity, urinary incontinence, epilepsy and smoking cessation, as well as linkurl:depression,;http://www.the-scientist.com/article/display/52980/ include a suicide assessment in their clinical trials. FDA researchers created a questionnaire that is becoming a mandatory part of some drug testing. Apparently, because of its level of detail, its use is so popular that it has been translated into 80 languages. The belief used to be that drugs that don't reach the brain have no effect on...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?